Integration of Imaging and Fluid-Based Tumor Monitoring Assays During Cancer Therapy
National Institutes of Health
Description
This grant is for projects that aim to combine imaging techniques and liquid biopsy tests during cancer treatment to improve how doctors track how well the treatment is working and identify any resistance to it.
This funding opportunity seeks applications for projects that integrate imaging and liquid biopsy assays during cancer therapy to optimize their use in monitoring therapy response and treatment resistance.
Source
Grant ID
PAR-25-175
Agency
National Institutes of Health
Subcategory/Subagency
National Cancer Institute
Key Dates
Opportunity Released
November 6, 2024
Open for Submission
November 6, 2024
Submission Deadline
January 7, 2028
Application Window Closes
January 7, 2028
Eligibility
The following categories of applicants are invited to apply:
- Public/State-Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Small Businesses
- For-Profit Organizations (Other than Small Businesses)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Local Governments (unspecified)
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Regional Organizations
Awards & Funding
Total Funding
$500,000
Award Ceiling
$500,000
Funding Amount
~$500,000
Similar opportunities
- Notice of Funding Opportunity (NOFO) for Revision Applications to Accelerate the Translation of NCI-Supported Methods/Assays/Technologies to the Clinic
National Institutes of Health
- Validation of Biomarkers for Cancer Detection, Diagnosis, and Treatment
National Institutes of Health
- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
Department of Health and Human Services
- Notice of Funding Opportunity (NOFO) for NCI R01 Research Projects
National Institutes of Health
- Development and Application of Molecular Imaging Methods to Study Cancer Inflammation
National Institutes of Health